Your browser doesn't support javascript.
loading
Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and ß-amyloid in ageing and Alzheimer's disease.
Weinreb, Orly; Amit, Tamar; Bar-Am, Orit; Youdim, Moussa B H.
Affiliation
  • Weinreb O; Eve Topf Centers of Excellence for Neurodegenerative Diseases Research, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Amit T; ABITAL Pharma Pipeline Ltd., Yokneam, Israel.
  • Bar-Am O; Eve Topf Centers of Excellence for Neurodegenerative Diseases Research, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Youdim MB; ABITAL Pharma Pipeline Ltd., Yokneam, Israel.
Br J Pharmacol ; 173(13): 2080-94, 2016 07.
Article in En | MEDLINE | ID: mdl-26332830
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aging / Cholinesterase Inhibitors / Amyloid beta-Peptides / Neuroprotective Agents / Alzheimer Disease / Iron / Monoamine Oxidase Inhibitors Limits: Animals / Humans Language: En Journal: Br J Pharmacol Year: 2016 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aging / Cholinesterase Inhibitors / Amyloid beta-Peptides / Neuroprotective Agents / Alzheimer Disease / Iron / Monoamine Oxidase Inhibitors Limits: Animals / Humans Language: En Journal: Br J Pharmacol Year: 2016 Document type: Article Affiliation country: Country of publication: